Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310016, China.
Pharm Res. 2022 Aug;39(8):1959-1968. doi: 10.1007/s11095-022-03303-0. Epub 2022 Jun 14.
In reducing capillary electrophoresis sodium dodecyl sulfate (CE-SDS) analysis of a monoclonal antibody (mAb-1), the peak area ratio of heavy chain (HC) to light chain (LC) was out of balance, while multiple artifact peaks were observed following the migration of HC. The main purposes of this study were to describe the techniques utilized to eliminate this artifact and clarify the root cause for this interesting phenomenon.
We optimized the CE-SDS analysis of mAb-1 by a vairety of techniques including changing the concentration of protein or replacing SDS with a more hydrophobic surfactant (i.e., sodium hexadecyl sulfate (SHS) or sodium tetradecyl sulfate (STS) instead of SDS) in sample and/or the sieving gel buffer. Dynamic light scattering (DLS) and reversed phase high-performance liquid chromatography (RP-HPLC) were used to study the protein-surfactant complex.
The artifact could be partially mitigated by reducing the protein concentration and replacing SDS with SHS or STS in the sample and/or the sieving gel buffer solutions. Due to replacing a more hydrophobic surfactant, the HC-surfactant complex formed was more resistant to dissociation, preventing additional hydrophobic HC-HC interaction and aggregation, thus eliminating the artifact problem.
DLS and RP-HPLC are powerful supplementary techniques in characterizing the protein-surfactant complex, and hydrophobic surfactants such as SHS and STS could afford more normal electropherograms during the analysis of mAbs.
在降低十二烷基硫酸钠毛细管电泳(CE-SDS)分析单克隆抗体(mAb-1)时,重链(HC)与轻链(LC)的峰面积比失衡,而 HC 迁移后观察到多个伪峰。本研究的主要目的是描述消除这种伪影的技术,并阐明这种有趣现象的根本原因。
我们通过多种技术优化了 mAb-1 的 CE-SDS 分析,包括改变蛋白质浓度或在样品和/或筛分凝胶缓冲液中用更疏水的表面活性剂(即十六烷基硫酸钠(SHS)或十四烷基硫酸钠(STS)代替 SDS)代替 SDS。动态光散射(DLS)和反相高效液相色谱(RP-HPLC)用于研究蛋白质-表面活性剂复合物。
通过降低蛋白质浓度并在样品和/或筛分凝胶缓冲液中用 SHS 或 STS 代替 SDS,可以部分减轻伪影。由于用更疏水的表面活性剂代替,形成的 HC-表面活性剂复合物更不易解离,防止了额外的疏水 HC-HC 相互作用和聚集,从而消除了伪影问题。
DLS 和 RP-HPLC 是表征蛋白质-表面活性剂复合物的有力补充技术,并且疏水性表面活性剂如 SHS 和 STS 可以在分析 mAbs 时提供更正常的电泳图谱。